Notice of Intent To Award Affordable Care Act Funding to Approved Applications Formerly Received in Response to the Centers for Disease Control and Prevention Funding Opportunity IP11-010, “Enhanced Surveillance for New Vaccine Preventable Disease”, 21906 [2011-9417]
Download as PDF
<![CDATA[
21906
Federal Register / Vol. 76, No. 75 / Tuesday, April 19, 2011 / Notices
request; object class, appropriation code
and Central Accounting Number (CAN)
of the item requested; HHS requesting
organization name; and location, HHS
point of contact name and business
contact phone number within the
requesting organization; a description of
the item requested and corresponding
quantity and cost required. Other
information collected includes;
proposal, solicitation, market research,
and contract award documentation.
SYSTEMS EXEMPTED FROM CERTAIN PROVISIONS
OF THE ACT:
None.
[FR Doc. 2011–9467 Filed 4–18–11; 8:45 am]
BILLING CODE 4150–24–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Intent To Award Affordable
Care Act Funding to Approved
Applications Formerly Received in
Response to the Centers for Disease
Control and Prevention Funding
Opportunity IP11–010, ‘‘Enhanced
Surveillance for New Vaccine
Preventable Disease’’
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
This notice provides public
announcement of CDC’s intent to fund
Approved cooperative agreement
applications previously received and
competed in response to CDC Funding
Opportunity, CDC–RFA–IP11–010,
‘‘Enhanced Surveillance for New
Vaccine Preventable Disease.’’ It is the
intent of CDC to fund the applications
with Patient Protection Affordable Care
Act (ACA), Section 4002,
appropriations.
CFDA Number 93.533 is the ACAspecific CFDA number for this
initiative.
mstockstill on DSKH9S0YB1PROD with NOTICES
SUMMARY:
Award Information
Approximate Current Fiscal Year
Funding: $2,750,000.
Approximate Number of Awards: 3–5.
Approximate Average Award:
$500,000.
Fiscal Year Funds: Patient Protection
and Affordable Health Care Act of 2011.
Anticipated Award Date: 31 May
2011.
Budget Period: 12 months.
Project Period: 5 years.
Application Selection Process: CDC
will apply the same selection
VerDate Mar<15>2010
16:19 Apr 18, 2011
Jkt 223001
methodology published in the FOA,
CDC–RFA–IP11–010.
The following will be considered in
making funding decisions:
• Scientific and technical merit of the
proposed project as determined by
scientific peer review.
• Availability of funds.
• Relevance of the proposed project
to program priorities.
• Funding decision criteria will
include a priority score, programmatic
importance/value relative to program
priorities, past and current surveillance
performance and capabilities, research
portfolio, geographic locations, and
study population consideration
(ethnicity, etc.)
• Preference may be given to a
medical institution catchment area
having a total population of greater than
500,000 persons.
• Applicants must have a letter of
support with a research laboratory for
rotavirus analyses or they will not be
funded.
CDC will add the following Authority
to that which is reflected in the
published Funding Opportunity:
—Section 4002 of the Patient Protection
and Affordable Care Act (Public Law
111–148.)
DATES: The effective date for this action
is April 19, 2011 and remains in effect
until the expiration of the project period
of the ACA funded applications..
FOR FURTHER INFORMATION CONTACT:
Elmira Benson, Deputy Director, Centers
for Disease Control and Prevention,
2920 Brandywine Road, Atlanta, GA
30341, telephone (770) 488–2802, e-mail
Elmira.Benson@cdc.gov.
SUPPLEMENTARY INFORMATION: On March
23, 2010, the President signed into law
the Patient Protection and Affordable
Care Act (ACA). ACA is designed to
improve and expand the scope of health
care coverage for Americans. Cost
savings through disease prevention is an
important element of this legislation
and ACA has established a Prevention
and Public Health Fund (PPHF) for this
purpose. Specifically, the legislation
states in Section 4002 that the PPHF is
to ‘‘provide for expanded and sustained
national investment in prevention and
public health programs to improve
health and help restrain the rate of
growth in private and public sector
health care costs. ACA and the
Prevention and Public Health Fund
make improving public health a priority
with investments to improve public
health.
The PPHF states that the Secretary
shall transfer amounts in the Fund to
accounts within the Department of
Health and Human Services to increase
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
funding, over the fiscal year 2008 level,
for programs authorized by the Public
Health Services Act, for prevention,
wellness and public health activities
including prevention research and
health screenings, such as the
Community Transformation Grant
Program, the Education and Outreach
Campaign for Preventative Benefits, and
Immunization Programs.
ACA legislation affords an important
opportunity to advance public health
across the lifespan and to reduce health
disparities by supporting an intensive
community approach to chronic disease
prevention and control.
Therefore, the FOA program activities
CDC proposes to fund with ACA
appropriations are authorized by the
amendment to the Public Health
Services Act which authorized the
Prevention and Wellness Program.
Dated: April 8, 2011.
John Murphy,
Business Operation Manager, Centers for
Disease Control and Prevention.
[FR Doc. 2011–9417 Filed 4–18–11; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60-Day–11–11EF]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Daniel Holcomb, CDC
Reports Clearance Officer, 1600 Clifton
Road, MS–D74, Atlanta, GA 30333 or
send an e-mail to omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
E:\FR\FM\19APN1.SGM
19APN1
]]>Agencies
[Federal Register Volume 76, Number 75 (Tuesday, April 19, 2011)]
[Notices]
[Page 21906]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-9417]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Intent To Award Affordable Care Act Funding to Approved
Applications Formerly Received in Response to the Centers for Disease
Control and Prevention Funding Opportunity IP11-010, ``Enhanced
Surveillance for New Vaccine Preventable Disease''
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice provides public announcement of CDC's intent to
fund Approved cooperative agreement applications previously received
and competed in response to CDC Funding Opportunity, CDC-RFA-IP11-010,
``Enhanced Surveillance for New Vaccine Preventable Disease.'' It is
the intent of CDC to fund the applications with Patient Protection
Affordable Care Act (ACA), Section 4002, appropriations.
CFDA Number 93.533 is the ACA-specific CFDA number for this
initiative.
Award Information
Approximate Current Fiscal Year Funding: $2,750,000.
Approximate Number of Awards: 3-5.
Approximate Average Award: $500,000.
Fiscal Year Funds: Patient Protection and Affordable Health Care
Act of 2011.
Anticipated Award Date: 31 May 2011.
Budget Period: 12 months.
Project Period: 5 years.
Application Selection Process: CDC will apply the same selection
methodology published in the FOA, CDC-RFA-IP11-010.
The following will be considered in making funding decisions:
Scientific and technical merit of the proposed project as
determined by scientific peer review.
Availability of funds.
Relevance of the proposed project to program priorities.
Funding decision criteria will include a priority score,
programmatic importance/value relative to program priorities, past and
current surveillance performance and capabilities, research portfolio,
geographic locations, and study population consideration (ethnicity,
etc.)
Preference may be given to a medical institution catchment
area having a total population of greater than 500,000 persons.
Applicants must have a letter of support with a research
laboratory for rotavirus analyses or they will not be funded.
CDC will add the following Authority to that which is reflected in
the published Funding Opportunity:
--Section 4002 of the Patient Protection and Affordable Care Act
(Public Law 111-148.)
DATES: The effective date for this action is April 19, 2011 and remains
in effect until the expiration of the project period of the ACA funded
applications..
FOR FURTHER INFORMATION CONTACT: Elmira Benson, Deputy Director,
Centers for Disease Control and Prevention, 2920 Brandywine Road,
Atlanta, GA 30341, telephone (770) 488-2802, e-mail
Elmira.Benson@cdc.gov.
SUPPLEMENTARY INFORMATION: On March 23, 2010, the President signed into
law the Patient Protection and Affordable Care Act (ACA). ACA is
designed to improve and expand the scope of health care coverage for
Americans. Cost savings through disease prevention is an important
element of this legislation and ACA has established a Prevention and
Public Health Fund (PPHF) for this purpose. Specifically, the
legislation states in Section 4002 that the PPHF is to ``provide for
expanded and sustained national investment in prevention and public
health programs to improve health and help restrain the rate of growth
in private and public sector health care costs. ACA and the Prevention
and Public Health Fund make improving public health a priority with
investments to improve public health.
The PPHF states that the Secretary shall transfer amounts in the
Fund to accounts within the Department of Health and Human Services to
increase funding, over the fiscal year 2008 level, for programs
authorized by the Public Health Services Act, for prevention, wellness
and public health activities including prevention research and health
screenings, such as the Community Transformation Grant Program, the
Education and Outreach Campaign for Preventative Benefits, and
Immunization Programs.
ACA legislation affords an important opportunity to advance public
health across the lifespan and to reduce health disparities by
supporting an intensive community approach to chronic disease
prevention and control.
Therefore, the FOA program activities CDC proposes to fund with ACA
appropriations are authorized by the amendment to the Public Health
Services Act which authorized the Prevention and Wellness Program.
Dated: April 8, 2011.
John Murphy,
Business Operation Manager, Centers for Disease Control and Prevention.
[FR Doc. 2011-9417 Filed 4-18-11; 8:45 am]
BILLING CODE 4163-18-P
